Despite this, drug makers Bristol-Myers Squibb and Otsuka Pharmaceuticals originally had chosen not to include a similar warning on Abilify sold in the U.S.Ĭompulsive gambling can lead to psychological distress, health problems, financial harm, and social consequences. But due to how the drug affects the brain, patients may develop a problem with impulse control that causes them to gamble uncontrollably.Įuropean and Canadian health officials found the association between Abilify and compulsive gambling strong enough to warrant updated product labeling to warn about this risk. Morgan & Morgan is pursuing lawsuits on behalf of patients who were prescribed the drug Abilify (aripiprazole) and developed compulsive gambling behaviors that lost them $50,000 or more.Ībilify, used to treat major depression, bipolar disorder, and schizophrenia, is the top-selling antipsychotic medication in the United States. Insurance Company Data Breach Attorneys.
